中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共265条，第1-10条 帮助

条数/页： 排序方式：
JC-010a, a novel selective SHP2 allosteric inhibitor, overcomes RTK/non-RTK-mediated drug resistance in multiple oncogene-addicted cancers 期刊论文  OAI收割
CANCER LETTERS, 2024, 卷号: 582, 页码: 15
作者:  Lu, Xuxiu;  Yu, Rilei;  Li, Zhen;  Yang, Mengke;  Dai, Jiajia
  |  收藏  |  浏览/下载：13/0  |  提交时间：2024/04/07
Epigenetic-based combination therapy and liposomal codelivery overcomes osimertinib-resistant NSCLC via repolarizing tumor-associated macrophages 期刊论文  OAI收割
ACTA PHARMACOLOGICA SINICA, 2023, 页码: 12
作者:  Lin, Ting-ting;  Xiong, Wei;  Chen, Gui-hua;  He, Yang;  Long, Li
  |  收藏  |  浏览/下载：6/0  |  提交时间：2024/01/26
From bench to bedside: current development and emerging trend of KRAS-targeted therapy 期刊论文  OAI收割
ACTA PHARMACOLOGICA SINICA, 2023, 页码: 18
作者:  Chen, Yi;  Liu, Qiu-pei;  Xie, Hua;  Ding, Jian
  |  收藏  |  浏览/下载：27/0  |  提交时间：2024/01/16
SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer 期刊论文  OAI收割
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 卷号: 8, 期号: 1, 页码: 13
作者:  Zhou, Ji;  Zhang, Xu-Chao;  Xue, Shan;  Dai, Mengdi;  Wang, Yueliang
  |  收藏  |  浏览/下载：12/0  |  提交时间：2023/10/17
AXL antibody and AXL-ADC mediate antitumor efficacy via targeting AXL in tumor-intrinsic epithelial-mesenchymal transition and tumor-associated M2-like macrophage 期刊论文  OAI收割
ACTA PHARMACOLOGICA SINICA, 2023, 页码: 14
作者:  Pei, Jin-peng;  Wang, Yue;  Ma, Lan-ping;  Wang, Xin;  Liu, Liang
  |  收藏  |  浏览/下载：21/0  |  提交时间：2023/04/10
Discovery of HCD3514 as a potent EGFR inhibitor against C797S mutation in vitro and in vivo 期刊论文  OAI收割
JOURNAL OF CANCER, 2023, 卷号: 14, 期号: 1, 页码: 152-162
作者:  Lai, Mengzhen;  Zhang, Tao;  Chen, Hao;  Song, Peiran;  Tong, Linjiang
  |  收藏  |  浏览/下载：80/0  |  提交时间：2023/04/10
A retrospective study on the efficacy and safety of Endostar with chemotherapy in EGFR-TKI-resistant NSCLC 期刊论文  OAI收割
BMC PULMONARY MEDICINE, 2023, 卷号: 23, 期号: 1
作者:  Bing Han;  Yanrong Kang;  Haiji Wang;  Jian Wang;  Rong Shen
  |  收藏  |  浏览/下载：26/0  |  提交时间：2024/01/26
Gefitinib enhances the anti-tumor immune response against EGFR-mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H 期刊论文  OAI收割
INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 卷号: 61
作者:  Guo, Huihui;  Zhang, Xilin;  Xie, Shangzhi;  Chen, Tianwei;  Xie, Dong
  |  收藏  |  浏览/下载：74/0  |  提交时间：2022/12/22
Deep learning for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: A multicentre study 期刊论文  OAI收割
EBIOMEDICINE, 2022, 卷号: 86, 页码: 13
作者:  She, Yunlang;  He, Bingxi;  Wang, Fang;  Zhong, Yifan;  Wang, Tingting
  |  收藏  |  浏览/下载：20/0  |  提交时间：2023/02/22
Loss of VOPP1 Contributes to BET Inhibitor Acquired Resistance in Non-Small Cell Lung Cancer Cells 期刊论文  OAI收割
MOLECULAR CANCER RESEARCH, 2022, 卷号: 20, 期号: 12, 页码: 1785-1798
作者:  Sun, Lin;  Wu, Qian;  Huan, Xia-Juan;  Tian, Chang-Qing;  Wang, Ying-Qing
  |  收藏  |  浏览/下载：12/0  |  提交时间：2024/03/21